Jornal Vascular Brasileiro
https://www.jvascbras.org/article/doi/10.1590/1677-5449.010816
Jornal Vascular Brasileiro
Review Article

Resultados a longo prazo da angioplastia de artérias renais com stent na doença aterosclerótica: revisão sistemática

Long term outcome of renal artery angioplasty with stenting for atherosclerotic stenosis: a systematic review

Daniel Emilio Dalledone Siqueira, Ana Terezinha Guillaumon

Downloads: 1
Views: 1141

Resumo

A doença renovascular aterosclerótica é a principal causa de hipertensão secundária. A história natural da doença demonstra taxas de progressão de 4 a 12% ao ano. Entre os métodos de tratamento existe a angioplastia com stent de artérias renais; porém, poucos estudos clínicos demonstraram seus resultados a longo prazo. Esta revisão sistemática da literatura se propõe a apresentar os resultados a longo prazo (acima de 24 meses) da angioplastia com stent de artérias renais na doença aterosclerótica em relação à função renal e aos níveis pressóricos no controle da hipertensão. Foi realizada uma ampla pesquisa, utilizando os termos apropriados, nas bases de dados LILACS, EMBASE, SCIELO, Cochrane Library e MEDLINE. De um total de 2.170 referências, apenas sete artigos contemplavam todos os critérios de inclusão. Conclui-se que, a longo prazo, há uma estabilização da função renal, redução dos níveis pressóricos e diminuição do número de classes de medicamentos anti-hipertensivos.

Palavras-chave

angioplastia; aterosclerose; hipertensão renovascular; nefropatia; obstrução da artéria rena

Abstract

Atherosclerotic renovascular disease is the most important cause of secondary hypertension. The natural history of the disease reveals progression rates of 4 to 12% per year. Angioplasty with renal artery stenting is one treatment option; but there are few studies that have reported long-term results. The objective of this systematic literature review is to discuss the long-term results (at least 24 months) of angioplasty with stenting of renal arteries for atherosclerotic disease, in terms of renal function and blood pressure levels for control of hypertension. A thorough search was conducted of LILACS, EMBASE, SCIELO, Cochrane Library, and MEDLINE using the appropriate terms. Just seven out of 2170 references identified met all inclusion criteria. It was concluded that over the long term renal function was stabilized, blood pressure levels were reduced, and the number of classes of antihypertensive medication decreased.

Keywords

angioplasty; atherosclerosis; renovascular hypertension; nephropathy; renal artery occlusion.

References

1. Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13-22. PMid:24245566. http://dx.doi.org/10.1056/NEJMoa1310753.

2. Guillaumon AT, Rocha EF, Medeiros CAF. Endovascular treatment of renal stenosis in solitary kidney. J Vasc Bras. 2008;7(2):99-105. http://dx.doi.org/10.1590/S1677-54492008000200003.

3. Minuz P, Patrignani P, Gaino S, et al. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation. 2002;106(22):2800-5. PMid:12451006. http://dx.doi.org/10.1161/01.CIR.0000039528.49161.E9.

4. Kuller LH, Shemanski L, Psaty BM, et al. Subclinical disease as an independent risk fa tor for cardiovascular disease. Circulation. 1995;92(4):720-6. PMid:7641349. http://dx.doi.org/10.1161/01.CIR.92.4.720.

5. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340(1):14-22. PMid:9878640. http://dx.doi.org/10.1056/NEJM199901073400103.

6. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19(3):538-45. PMid:10073955. http://dx.doi.org/10.1161/01.ATV.19.3.538.

7. Yu H, Zhang D, Haller S, et al. Determinants of renal function in patients with renal artery stenosis. Vasc Med. 2011;16(5):331-8. PMid:21908683. http://dx.doi.org/10.1177/1358863X11419998.

8. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31(3):823-9. PMid:9495267. http://dx.doi.org/10.1161/01.HYP.31.3.823.

9. van Jaarsveld BC, Derkx FH, Krijnen P, et al. ‘Hypertension resistant to two-drug treatment’ is a useful criterion to select patients for angiography: the ‘Dutch Renal Artery Stenosis Intervention Cooperative’ (DRASTIC) study. Contrib Nephrol. 1996;119:54-8. PMid:8783591. http://dx.doi.org/10.1159/000425449.

10. Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953-62. PMid:19907042. http://dx.doi.org/10.1056/NEJMoa0905368.

11. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344(6):431-42. PMid:11172181. http://dx.doi.org/10.1056/NEJM200102083440607.

12. Perkovic V, Thomson KR, Mitchell PJ, et al. Treatment of renovascular disease with percutaneous stent insertion: Long-term outcomes. Australas Radiol. 2001;45(4):438-43. PMid:11903175. http://dx.doi.org/10.1046/j.1440-1673.2001.00953.x.

13. Guzman RP, Zierler RE, Isaacson JA, Bergelin RO, Strandness DE Jr. Renal atrophy and arterial stenosis: a prospective study with duplex ultrasound. Hypertension. 1994;23(3):346-50. PMid:8125561. http://dx.doi.org/10.1161/01.HYP.23.3.346.

14. Zierler RE, Bergelin RO, Davidson RC, Cantwell-Gab K, Polissar NL, Strandness DE Jr. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens. 1996;9(11):1055-61. PMid:8931829. http://dx.doi.org/10.1016/0895-7061(96)00196-3.

15. Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC. Effect of renal artery stenting on renal function and size in patients with Atherosclerotic Renovascular Disease. Circulation. 2000;102(14):1671-7. PMid:11015346. http://dx.doi.org/10.1161/01.CIR.102.14.1671.

16. Rodriguez Lopez JA, Werner A, Ray LI, et al. Renal artery stenosis treated with stent deployment: Indications, technique, and outcome for 108 patients. J Vasc Surg. 1999;29(4):617-24. PMid:10194488. http://dx.doi.org/10.1016/S0741-5214(99)70306-X.

17. Fiala LA, Jackson MR, Gillespie DL, O’Donnell SD, Lukens M, Gorman P. Primary stenting of atherosclerotic renal artery ostial stenosis. Ann Vasc Surg. 1998;12(2):128-33. PMid:9514229. http://dx.doi.org/10.1007/s100169900128.

18. Ruchin PE, Baron DW, Wilson SH, Boland J, Muller DWM, Roy PR. Long term follow-up of renal artery stenting in an Australian population. Heart Lung Circ. 2007;16(2):79-84. PMid:17317314. http://dx.doi.org/10.1016/j.hlc.2006.12.008.

19. Zhao J, Cheng Q, Zhang X, Li M, Liu S, Wang X. Efficacy of percutaneous transluminal renal angioplasty with stent in elderly male patients with atherosclerotic renal artery stenosis. Clin Interv Aging. 2012;7:417-22. PMid:23091375. http://dx.doi.org/10.2147/CIA.S36925.

20. Chuan-jun L, Bao-zhong Y, Zhong-gao W. Percutaneous transluminal renal angioplasty with stent is effective for blood pressure control and renal function improvement in atherosclerotic renal artery stenosis patients. Chin Med J. 2012;125(8):1363-8. PMid:22613636.

21. Zeller T, Müller C, Frank U, et al. Survival after stenting of severe atherosclerotic ostial renal artery stenoses. J Endovasc Ther. 2003;10(3):539-45. PMid:12932166. http://dx.doi.org/10.1177/152660280301000320.

22. Bucek RA, Puchner S, Reiter M, Dirisamer A, Minar E, Lammer J. Long-term follow-up after renal artery stenting. Wien Klin Wochenschr. 2003;115(21-22):788-92. PMid:14743583. http://dx.doi.org/10.1007/BF03040504.

23. Bright R. Cases and observations illustrative of renal disease accompanied with the secretion of albuminous urine. Guys Hosp Rep. 1836;1:338-79.

24. Traube L. Ueber den zusammenhand von herz und nieren krankheiten. In: Hirschwald A, editor. Gesammelte Beitraege zur Pathologie und Physiologie. Berlin: Hirschwald; 1871. vol. 2.

25. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59(3):347-79. PMid:19870251. http://dx.doi.org/10.1084/jem.59.3.347.

26. Grüntzig A, Vetter W, Meier B, Kuhlmann U, Lütolf U, Siegenthaler W. Treatment of renovascular hypertension with percutaneous transluminal dilatation of renal-artery stenosis. Lancet. 1978;311(8068):801-2. PMid:85817. http://dx.doi.org/10.1016/S0140-6736(78)93000-3.

27. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. N Engl J Med. 2000;342(14):1007-14. PMid:10749962. http://dx.doi.org/10.1056/NEJM200004063421403.

28. Sivamurthy N, Surowiec SM, Culakova E, et al. Divergent outcomes after percutaneous therapy for symptomatic renal artery stenosis. J Vasc Surg. 2004;39(3):565-74. PMid:14981450. http://dx.doi.org/10.1016/j.jvs.2003.09.024.

29. Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann Intern Med. 2009;150(12):840-8, W150-1. PMid:19414832. http://dx.doi.org/10.7326/0003-4819-150-12-200906160-00119.

30. Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953-62. PMid:19907042. http://dx.doi.org/10.1056/NEJMoa0905368.

31. Conlon PJ, Athirakul K, Kovalik E, et al. Survival in renal vascular disease. J Am Soc Nephrol. 1998;9(2):252-6. PMid:9527401.

32. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60(4):1490-7. PMid:11576364. http://dx.doi.org/10.1046/j.1523-1755.2001.00953.x.

33. Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med. 1990;88(1N):46N-51N. PMid:2368764.

34. Olin JW, Froehlich J, Gu X, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182-90. PMid:22615343. http://dx.doi.org/10.1161/CIRCULATIONAHA.112.091223.

35. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984;11(3):383-92. PMid:6464247.

36. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE Jr. Natural history of atherosclerotic renal artery stenosis: a prospective study with doppler ultrassonography. J Vasc Surg. 1994;19(2):250-8. PMid:8114186. http://dx.doi.org/10.1016/S0741-5214(94)70100-8.

37. Caps MT, Zierler RE, Polissar NL, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53(3):735-42. PMid:9507221. http://dx.doi.org/10.1046/j.1523-1755.1998.00805.x.

38. Postma CT, Joosten FB, Rosenbusch G, Thien T. Magnetic resonance angiography has a high reliability in the detection of renal artery stenosis. Am J Hypertens. 1997;10(9):957-63. PMid:9324099. http://dx.doi.org/10.1016/S0895-7061(97)00157-X.

Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)"> Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV)">
5cd4771f0e8825d22b7f3257 jvb Articles

J Vasc Bras

Share this page
Page Sections